نتائج البحث - "Nicolas Mach"

1

Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort Study

المؤلفون: Pierre-Yves Dietrich, Kaklamani, Hudson Rd, Alfredo Addeo, Robin J. Leach, Albracht B, Wang J, Shah P, Lathrop K, Fertani S, Ruben A. Mesa, Shah D, José Luis Sandoval, Patel D, Bordry N, Marco, Nicolas Mach, Simand P, Barbara S. Taylor, Intidhar Labidi-Galy

مصطلحات موضوعية: education.field_of_study, medicine.medical_specialty, Cancer prevention, business.industry, Population, Cancer, medicine.disease, Clinical trial, Vaccination, Family medicine, medicine, Seroconversion, Prospective cohort study, education, business, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b36622afbb08f5af7cfb9d2d324a70c6Test
https://doi.org/10.21203/rs.3.rs-554993/v1Test

2

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040

المؤلفون: Jonathan D. Cheng, Barbara Burtness, José Dinis, Misoo C. Ellison, Nicolas Mach, Christophe Le Tourneau, Diana Chirovsky, Ainara Soria, Ramona F. Swaby, Lisa Licitra, Kevin J. Harrington, Denis Soulières, Myung-Ju Ahn, Ranee Mehra, Ezra E.W. Cohen, Jean-Pascal Machiels

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service d'oto-rhino-laryngologie, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Unité d'oncologie médicale

المصدر: Journal of the National Cancer Institute, Vol. 113, no.2, p. 171-181 (2021)
J Natl Cancer Inst
Journal of the National Cancer Institute, vol 113, iss 2
Journal of the National Cancer Institute, Vol. 113, No 2 (2021) pp. 171-181

مصطلحات موضوعية: Oncology, Male, Cancer Research, Cetuximab, Pembrolizumab, Docetaxel, 0302 clinical medicine, Quality of life, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Neoplasm Metastasis, Humanized, Cancer, ddc:616, Aged, 80 and over, 0303 health sciences, education.field_of_study, Hazard ratio, Articles, Middle Aged, humanities, Local, 030220 oncology & carcinogenesis, Cancer methotrexate organizations platinum world health quality of life docetaxel cetuximab head and neck squamous cell carcinoma health-related quality of life european organization for research and treatment of cancer standard of care pembrolizumab, medicine.drug, Adult, medicine.medical_specialty, Population, Oncology and Carcinogenesis, Antibodies, Monoclonal, Humanized, Antibodies, Disease-Free Survival, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, medicine, Humans, Oncology & Carcinogenesis, Patient Reported Outcome Measures, Dental/Oral and Craniofacial Disease, education, 030304 developmental biology, Aged, business.industry, Squamous Cell Carcinoma of Head and Neck, medicine.disease, Head and neck squamous-cell carcinoma, Regimen, Neoplasm Recurrence, Good Health and Well Being, Quality of Life, Neoplasm Recurrence, Local, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c605279800d9cce11c0a442019697bbTest
https://hdl.handle.net/2078.1/245855Test

3

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

المصدر: Cancer Cell, Vol. 39, No 8 (2021) pp. 1091-1098.e2
Cancer Cell

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db4d295de5d547213400ac5149e903fTest
https://archive-ouverte.unige.ch/unige:155812Test

4

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

المؤلفون: Ezra E W Cohen, Denis Soulières, Christophe Le Tourneau, José Dinis, Lisa Licitra, Myung-Ju Ahn, Ainara Soria, Jean-Pascal Machiels, Nicolas Mach, Ranee Mehra, Barbara Burtness, Pingye Zhang, Jonathan Cheng, Ramona F Swaby, Kevin J Harrington, Mirelis Acosta-Rivera, Douglas R. Adkins, Morteza Aghmesheh, Mario Airoldi, Eduardas Aleknavicius, Yousuf Al-Farhat, Alain P. Algazi, Salah Almokadem, Anna Alyasova, Jessica R. Bauman, Marco Benasso, Alfonso Berrocal, Victoria Bray, Barbara Ann Burtness, Francesco Caponigro, Ana Castro, Terrence P. Cescon, Kelvin Chan, Arvind Chaudhry, Bruno Chauffert, Ezra Cohen, Tibor Csoszi, J.P. De Boer, Jean-Pierre Delord, Andreas Dietz, Jose Dinis, Charlotte Dupuis, Laurence Digue, Jozsef Erfan, Yolanda Escobar Alvarez, Mererid Evans, Mary Jo Fidler, Martin David Forster, Signe Friesland, Apar K. Ganti, Lionnel Geoffrois, Cliona Grant, Viktor Gruenwald, Kevin Harrington, Thomas Hoffmann, Geza Horvai, Arturas Inciura, Raymond Jang, Petra Jankowska, Antonio Jimeno, Mano Joseph, Alejandro Juarez Ramiro, Boguslawa Karaszewska, Andrzej Kawecki, Ulrich Keilholz, Ulrich Keller, Sung-Bae Kim, Judit Kocsis, Nuria Kotecki, Mark F. Kozloff, Julio Lambea, Laszlo Landherr, Yuri Lantsukhay, Sergey Alexandrovich Lazarev, Lip Way Lee, Igor Dmitrievich Lifirenko, Danko Martincic, Oleg Vladmirovhich Matorin, Margaret McGrath, Krzysztof Misiukiewicz, John C. Morris, Fagim Fanisovich Mufazalov, Jiaxin Niu, Devraj Pamoorthy Srinivasan, Pedro Perez Segura, Daniel Rauch, Maria Leonor Ribeiro, Cristina Rodriguez, Frederic Rolland, Antonio Russo, Agnes Ruzsa, Frederico Sanches, Sang-Won Shin, Mikhail Shtiveland, Denis Soulieres, Pol Specenier, Eva Szekanecz, Judit Szota, Carla M.L. van Herpen, Hector A. Velez-Cortes, William V. Walsh, Stefan Wilop, Ralph Winterhalder, Marek Wojtukiewicz, Deborah Wong, Dan Zandberg

المساهمون: KEYNOTE-040 investigators, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Unité d'oncologie médicale

المصدر: The Lancet, Vol. 393, No 10167 (2019) pp. 156-167
The lancet : international edition
Lancet, Vol. 393, no. 10167, p. 156-167 (2019)

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Combination therapy, Population, Cetuximab, Phases of clinical research, Docetaxel, Kaplan-Meier Estimate, Pembrolizumab, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, education, Aged, ddc:616, education.field_of_study, Squamous Cell Carcinoma of Head and Neck, business.industry, Hazard ratio, General Medicine, Middle Aged, Methotrexate, Head and Neck Neoplasms, Disease Progression, Female, Human medicine, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2fa1f3e2ce98a5be2c51dc208c21406Test
https://archive-ouverte.unige.ch/unige:155811Test

5

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors

المؤلفون: Dagmar Hess, Juergen Zieschang, Volker Lennerz, Thomas Woelfel, Stefanie Gross, Alexander Knuth, Cristiana Sessa, Elisa Gallerani, Lotta von Boehmer, Nicolas Mach, Ulf Forssmann, Ulrike Gnad-Vogt, Adrian F. Ochsenbein, Eckhart Kaempgen, Steffen Boehm

المصدر: Cancer immunology immunotherapy : CII
Lennerz, Volker; Gross, Stefanie; Gallerani, Elisa; Sessa, Cristiana; Mach, Nicolas; Boehm, Steffen; Hess, Dagmar; von Boehmer, Lotta; Knuth, Alexander; Ochsenbein, Adrian; Gnad-Vogt, Ulrike; Zieschang, Juergen; Forssmann, Ulf; Woelfel, Thomas; Kaempgen, Eckhart (2014). Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer immunology, immunotherapy, 63(4), pp. 381-394. Springer 10.1007/s00262-013-1516-5 <http://dx.doi.org/10.1007/s00262-013-1516-5Test>

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Survivin, T-Lymphocytes, medicine.medical_treatment, Immunology, Population, Dose-Response Relationship, Immunologic, Epitopes, T-Lymphocyte, 610 Medicine & health, T-Cell Antigen Receptor Specificity, Cancer Vaccines, Inhibitor of Apoptosis Proteins, HLA-B7 Antigen, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Internal medicine, medicine, Humans, Immunology and Allergy, Adverse effect, education, 030304 developmental biology, 0303 health sciences, education.field_of_study, HLA-A Antigens, business.industry, ELISPOT, Immunogenicity, Vaccination, Immunotherapy, Middle Aged, Peptide Fragments, Neoplasm Proteins, 3. Good health, Tolerability, 030220 oncology & carcinogenesis, Female, business, Interferon-gamma Release Tests